Curious about working in psychedelics?

In a brief conversational exchange, two speakers discuss the explosive growth of interest in psychedelic medicine in the United States, noting that 39 million people identify as "psychedelic curious" and that psychedelics are becoming a hot topic in therapy. They highlight the lack of reliable resources for safe use, the widespread microdosing of psilocybin mushrooms, and the powerful therapeutic potential—citing a single-session breakthrough in heroin addiction. The dialogue also references recent regulatory movement, with the DEA asking Health and Human Services to reschedule psilocybin from Schedule I, suggesting that tens of millions may soon experience psilocybin under more permissive conditions. Throughout, the speakers stress the need for professional supervision and proper retreat options.











